The emerging therapy of tirzepatide peptide represents a significant advance in the management of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide839134.dgbloggers.com/42443411/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment